This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
9 Jun 2015

10th Anniversary of RDD Europe: a Great Success for the International Respiratory Drug Delivery Community

From 5 to 8 May, RDD Europe 2015, recognized internationally by experts for the quality of its programme,
attracted delegates from Europe (61%), North America (23%) and the rest of the world’s aerosol community
(16%).


RDD Europe is a prestigious event, bringing together scientists, clinicians, business professionals and regulators to further research, development, clinical evaluation and marketing of current and new drugs delivered through the lungs or nose. Its focus is development of innovative products and services to meet patient needs.


RDD Europe 2015 hosted 22 speakers, 65 scientific poster presenters, 60 exhibitors and 12 interactive workshops.


Topics included:

•  Back to Biotech-Personalised Medicine and New Drug Development
•  Global Patent Practice
•  Nasal Drug Delivery
•  Pulmonary and Nasal Delivery: Exploring Alternative Technologies
•  Particle Engineering and Quality by Design
•  Alternative Distribution Practices for Inhalers.


RDD Online and Aptar Pharma, the joint organizers of this scientific conference are extremely pleased that the
audience found this year’s European meeting to be of outstanding quality with a record number of scientific posters.

 

Tenth Anniversary Celebration

RDD Europe celebrated its 10th anniversary in Antibes, although the parent US conference began in 1988.
Aptar Pharma has been part of RDD meetings from the outset, but in 2005 partnered with RDD to formally
lend its expertise in nasal and pulmonary drug administration and to increase the accessibility of the meeting
to international delegates. In Antibes, Aptar Pharma sponsored the gala dinner, providing attendees with an
additional opportunity to network and exchange views and information with their peers in a friendly and convivial atmosphere — another facet of this 3-day conference that sets RDD Europe apart from other events.


“Aptar Pharma is particularly proud of supporting, and being affiliated with, this major conference. The successful outcome of this tenth anniversary of RDD Europe and feedback from the delegates are a source of great satisfaction for all those involved“, stated Pierre Carlotti, Vice President Marketing and Communication at Aptar Pharma, Prescription, and Conference Coordinator at RDD Europe.


“The quality of the contributions this year was outstanding, reflecting major advances in our industry and the
importance of this conference, which brings together key players in the respiratory drug delivery sector“, added Dr Richard Dalby, one of the organizers from the University of Maryland.

Related News